Realyze Intelligence’s Post

Elevating patient voices is one of our ongoing priorities. The most powerful and informative way for potential clinical trial participants to learn what participation is like is to hear from someone who has been through it. #clinicaltrials #patientcentricity #patientvoice

Can't wait. This time it's not anymore about visions. AI algorithms, remote patient monitoring, Digital Therapeutics and Biomarker have become concrete realities in Rheumatology. Let's talk about it!

MERIT provided fast, accurate reads to support the quick turnaround times of a biotech's retrospective review of an early phase Glioma study. Read our latest #oncology case study to learn more: https://lnkd.in/g-RCQrVG #MERITCRO #YourClinicalEndpointExpert #glioma #clinicalresearch #clinicaltrials #oncology #imagingsolutions #casestudy

Dear Friends of the Peer Medical Foundation, Happy Clinical Trials Day!!! Today, May 20 sheds light on the importance of clinical trial participation to advance research and treatment to improve patients lives. As stated by the FDA: “Clinical trials are the safest way to find new treatments and ways to improve health. Some people participate in clinical trials because none of the current treatment options have worked, or they can’t tolerate certain side effects of existing treatments. Others participate in trials because they want to contribute to the advancement of medical knowledge. Regardless of their reasoning, it is critical that participants are protected through a robust informed consent process.” We can all work together to promote equity in clinical trials and research, join us at the Peer Medical Foundation, now! #PeerMedicalFoundation #ClinicalTrials #PeerMedDiversity #ClinicalTrialsDay #HealthEquity #ClinicalResearch #Oncology #CancerResearch

Clinical research is so important in providing patients greater access to medicines that can save lives. I'm proud to share Icon Group's Annual Research Report, showcasing the remarkable achievements of our clinical trial teams Slade Health. In 2023, Slade Health provided support to over 320 clinical trials, compounded 7,420 clinical trial products for over 1,000 trial patients. Our state-of-the-art compounding capabilities at our five TGA and Medsafe licensed facilities across Australia and New Zealand have been integral in supporting our hospital partners' efforts to advance healthcare outcomes. Learn more about our impact in the full report below. Click to read the full report: https://lnkd.in/gthXswq9 #research #cancerresearch #compounding #clinicaltrials 

6th edition already… a must-attend, human-sized conference on Digital health in Rheumatology where interactions and expertise are at the center of the event.

💡 In our community, a belief that keeps us together is that the future of healthcare is personalized, as well as the process of shared decision-making with patients. This approach requires empowered HCPs who can confidently communicate complex biomarker testing (cBT) results to patients. The challenge is that the complexities of comprehensive biomarker testing (cBT) demand advanced genomics knowledge and effective communication skills from HCPs. In this context, medical societies can significantly impact patient care by: ✔Advocating for educational programs that equip HCPs with the knowledge and confidence to navigate cBT and its implications. ✔Integrating shared decision-making models into clinical practice, empowering patients to actively participate in treatment choices based on their cBT results. 👉 These insights are from our recent publication 𝙐𝙣𝙙𝙚𝙧𝙨𝙩𝙖𝙣𝙙𝙞𝙣𝙜 𝙘𝙤𝙢𝙢𝙪𝙣𝙞𝙘𝙖𝙩𝙞𝙤𝙣 𝙗𝙚𝙩𝙬𝙚𝙚𝙣 𝙥𝙖𝙩𝙞𝙚𝙣𝙩𝙨 𝙖𝙣𝙙 𝙝𝙚𝙖𝙡𝙩𝙝𝙘𝙖𝙧𝙚 𝙥𝙧𝙤𝙛𝙚𝙨𝙨𝙞𝙤𝙣𝙖𝙡𝙨 𝙧𝙚𝙜𝙖𝙧𝙙𝙞𝙣𝙜 𝙘𝙤𝙢𝙥𝙧𝙚𝙝𝙚𝙣𝙨𝙞𝙫𝙚 𝙗𝙞𝙤𝙢𝙖𝙧𝙠𝙚𝙧 𝙩𝙚𝙨𝙩𝙞𝙣𝙜 𝙞𝙣 𝙥𝙧𝙚𝙘𝙞𝙨𝙞𝙤𝙣 𝙤𝙣𝙘𝙤𝙡𝙤𝙜𝙮: 𝘼 𝙨𝙘𝙤𝙥𝙞𝙣𝙜 𝙧𝙚𝙫𝙞𝙚𝙬, which you can access here. And share it with your community! https://bit.ly/43DyXQn

"In Gary's situation, he was one of the first 20 patients who was enrolled and treated with this [#drug] combination. And it's because of Gary's participation in that trial that we figured out that not only is this effective, it can be effective for years and years of time. And now it's FDA approved across the world." - Dr. Joshua Lang, UW Carbone Cancer Center "They gave me an opportunity to live, and we've created a drug that's going to give those people with the same condition as me an option." - Gary Davey View the video below to learn more about Mr. Davey's inspiring journey. #cancer #clinicaltrials #clinicalresearch #university #Wisconsin #FDA

Have you tried searching for rectal cancer clinical trials via CancerCare's myTRIAList clinical trial finder yet? Watch trial overview videos, including the AZUR-1 study overview video, that are designed to explain study details in plain language. https://buff.ly/4aNkFA2 #rectalcancer #cancerresearch #pharmaceuticalindustry #biotech

How to report clinical trial results effectively 💡   In 2023, over 22,000 clinical trials kicked off, highlighting how busy the year was for medical research. With oncology and central nervous system studies leading the pack, there's a lot of new information to share and report.    Pro tips to report your clinical trial results:   ✔️Clearly outline your trial's objective, design, and methodology; ✔️Be transparent and share all results, good or bad; ✔️Adhere to established reporting standards like CONSORT or STROBE; ✔️Use charts and graphs for clarity and visual assistance; ✔️Provide an easy-to-understand research overview; ✔️Discuss what your results mean for the field; ✔️Make it accessible by publishing in peer-reviewed and open-access journals; ✔️Reach the audience through media by crafting press releases that highlight the key findings.   By following these steps, you can report your clinical trial results in a way that's comprehensive, clear, and conducive to advancing healthcare and scientific understanding.